Using Mesenchymal Stem Cell-Derived Vesicles to Treat Bowel Transplant Rejection in Children and Adults
Mesenchymal stem cells (MSCs) are emerging as a promising avenue in the quest for novel therapies to combat solid organ transplant rejection. Despite their potential,